Federal Register / Vol. 74, No. 39 / Monday, March 2, 2009 / Notices 9107 

entities (‘‘Contributing Settling 

Defendants’’) with respect to the 

groundwater contamination and its 

investigation and treatment as set forth 

in the Interim Record of Decision, as 

modified by the Explanation of 

Significant Differences. The Consent 

Decree requires the Performing Settling 

Defendant, on behalf of all of the 

Settling Defendants, to construct the 

intermediate zone remedy to address 

groundwater contamination and operate 

it for eight years from the operational 

and functional date of the groundwater 

treatment system for the intermediate 

zone at an estimated cost of $21 million, 

pay $465,420.90 to EPA for past costs, 

and pay $90,000 to DTSC for past 

response costs. The Performing Settling 

Defendant represents that between 2002 

and June 30, 2007, it incurred costs in 

excess of seven million dollars ($7 

million) to implement the intermediate 

zone remedial action in compliance 

with the Unilateral Administrative 

Order No. 2002–06 issued on March 21, 

2002, pending negotiations of the 

Consent Decree. Settling Defendants 

who currently own source properties 

within the PVOU are required to 

provide access and all of the Settling 

Defendants are required to retain 

records and provide EPA access to 

information. The Consent Decree gives 

all Settling Defendants a covenant not to 

sue. The Consent Decree reserves the 

United States’ right to sue the Settling 

Defendants for the final Record of 

Decision and is subject to standard 

reopeners and reservations of rights. 

The Department of Justice will 

receive, for a period of thirty (30) days 

from the date of this publication, 

comments relating to the Consent 

Decree. Comments should be addressed 

to the Assistant Attorney General, 

Environment and Natural Resources 

Division, and either e-mailed to 

pubcomment-ees.enrd@usdoj.gov or 

mailed to P.O. Box 7611, U.S. 

Department of Justice, Washington, DC 

20044–7611, and should refer to United 

States v. Northrop Grumman Space & 

Mission Systems Corp., D.J. Ref. 90–11– 

2–354/16. Commenters may request an 

opportunity for a public meeting in the 

affected area, in accordance with 

Section 7003 of RCRA, 42 U.S.C. 

6973(d). 

The Consent Decree may be examined 

at U.S. EPA Region IX at 75 Hawthorne 

Street, San Francisco, California 94105. 

During the public comment period, the 

Consent Decree may also be examined 

on the following Department of Justice 

Web site, to http://www.usdoj.gov/enrd/ 

Consent_Decrees.html. A copy of the 

Consent Decree may also be obtained by 

mail from the Consent Decree Library, 

P.O. Box 7611, U.S. Department of 

Justice, Washington, DC 20044–7611 or 

by faxing or e-mailing a request to Tonia 

Fleetwood tonia.fleetwood@usdoj.gov, 

fax no. (202) 514–0097, phone 

confirmation number (202) 514–1547. In 

requesting a copy from the Consent 

Decree Library, please enclose a check 

in the amount of $95.50 (25 cents per 

page reproduction cost) payable to the 

U.S. Treasury or, if by e-mail or fax, 

forward a check in that amount to the 

Consent Decree Library at the stated 

address. 

Henry Friedman, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. E9–4367 Filed 2–27–09; 8:45 am] 

BILLING CODE 4410–15–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a registration under 21 U.S.C. 

952(a)(2), authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with Title 21 

Code of Federal Regulations 1301.34(a), 

this is notice that on December 22, 2008, 

Sigma Aldrich Manufacturing LLC., 

3500 Dekalb Street, St. Louis, Missouri 

63118, has made application by renewal 

to the Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the basic classes of controlled 

substances listed in schedule I and II: 

Drug Schedule 

Cathinone (1235) .......................... I 

Methcathinone (1237) .................. I 

Aminorex (1585) ........................... I 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) ................... I 

Alpha-ethyltryptamine (7249) ....... I 

Ibogaine (7260) ............................ I 

Lysergic acid diethylamide (7315) I 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Mescaline (7381) .......................... I 

4-Bromo-2,5- 

dimethoxyamphetamine (7391).

I 

4-Bromo-2,5- 

dimethoxyphenethylamine 

(7392).

I 

Drug Schedule 

4-Methyl-2,5- 

dimethoxyamphetamine (7395).

I 

2,5-Dimethoxyamphetamine 

(7396).

I 

3,4-Methylenedioxyamphetamine 

(7400).

I 

N-Hydroxy-3,4- 

methylenedioxyamphetamine 

(7402).

I 

3,4-Methylenedioxy-Nethylamphetamine (7404).I 

3,4- 

Methylenedioxymethamphetamine (MDMA) (7405).

I 

4-Methoxyamphetamine (7411) ... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

1-[1-(2- 

Thienyl)cyclohexyl]piperdine 

(7470).

I 

N-Benzylpiperazine (BZP) (7493) I 

Heroin (9200) ............................... I 

Normorphine (9313) ..................... I 

Etonitazene (9624) ....................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Nabilone (7379) ............................ II 

Phencyclidine (7471) .................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Diprenorphine (9058) ................... II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Ecgonine (9180) ........................... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levorphanol (9220) ...................... II 

Meperidine (9230) ........................ II 

Methadone (9250) ........................ II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Opium powdered (9639) .............. II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Fentanyl (9801) ............................ II 

The company plans to import the 

listed controlled substances for sale to 

research facilities for drug testing and 

analysis. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic classes of controlled 

substances may file comments or 

objections to the issuance of the 

proposed registration and may, at the 

same time, file a written request for a 

hearing on such application pursuant to 

21 CFR 1301.43, and in such form as 

prescribed by 21 CFR 1316.47. 

Any such comments or objections 

should be addressed, in quintuplicate, 


erowe on PROD1PC63 with NOTICES
9108 Federal Register / Vol. 74, No. 39 / Monday, March 2, 2009 / Notices 

to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than April 1, 2009. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

§ 1301.34(b), (c), (d), (e), and (f). As 

noted in a previous notice published in 

the Federal Register on September 23, 

1975, (40 FR 43745–46), all applicants 

for registration to import the basic class 

of any controlled substance in schedule 

I or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: February 23, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–4271 Filed 2–27–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Submission for OMB Emergency 

Review: Comment Request 

February 24, 2009. 

The Department of Labor has 

submitted the following information 

collection request (ICR), utilizing 

emergency review procedures, to the 

Office of Management and Budget 

(OMB) for review and clearance in 

accordance with the Paperwork 

Reduction Act of 1995 (Pub. L. 104–13, 

44 U.S.C. Chapter 35) and 5 CFR 

1320.13. OMB approval has been 

requested by March 10, 2009. A copy of 

this ICR, with applicable supporting 

documentation; including among other 

things a description of the likely 

respondents, proposed frequency of 

response, and estimated total burden 

may be obtained from the RegInfo.gov 

Web site at http://www.reginfo.gov/ 

public/do/PRAMain or by contacting 

Darrin King on 202–693–4129 (this is 

not a toll-free number)/e-mail: 

DOL_PRA_PUBLIC@dol.gov. Interested 

parties are encouraged to send 

comments to the Office of Information 

and Regulatory Affairs, Attn: OMB Desk 

Officer for the Department of Labor— 

ETA, Office of Management and Budget, 

Room 10235, Washington, DC 20503, 

Telephone: 202–395–7316/Fax: 202– 

395–6974 (these are not toll-free 

numbers), E-mail: 

OIRA_submission@omb.eop.gov. 

Comments and questions about the ICR 

listed below should be received 5 days 

prior to the requested OMB approval 

date. 

The OMB is particularly interested in 

comments which: 

• Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

• Enhance the quality, utility, and 

clarify of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

Agency: Employment and Training 

Administration. 

Title of Collection: Recovery Act— 

Applications for Unemployment 

Insurance Modernization Incentive 

Payments. 

OMB Control Number: Pending. 

Frequency of Collection: One time 

collection. 

Affected Public: State Workforce 

Agencies. 

Total Estimated Number of 

Respondents: 53. 

Total Estimated Annual Burden 

Hours: 424. 

Total Estimated Annual Costs Burden 

(other than hourly costs): $0. 

Description: Section 2003(f) of the 

American Recovery and Reinvestment 

Act of 2009 (ARRA) provides for 

unemployment insurance (UI) 

‘‘modernization incentive payments’’ to 

be made from the Unemployment Trust 

Fund (UTF) to the states. The total 

amount available for all states is $7 

billion dollars. To obtain its share, the 

state must make an application to the 

Department of Labor demonstrating that 

its UI law contains certain benefit 

eligibility provisions. The last date on 

which an incentive distribution may be 

made is September 30, 2011. When 

applying for a share of the UI 

modernization incentive payments, a 

state must document that the provisions 

of its law meet the requirements for 

obtaining an incentive payment. The 

state is also required to describe how it 

intends to use any incentive payment to 

improve or strengthen its UI program. 

Why are we requesting Emergency 

Processing? If DOL were to comply with 

standard PRA clearance procedures, it 

would not be able to comply with the 

ARRA-mandated payment schedule 

because procedures for these payments 

must be in place immediately. The 

statute provides that states need the 

means to access the funds as soon as 

possible. Otherwise, harm to the 

nation’s economic recovery could 

ensue. Finally, in preparing the 

guidelines, the Department has taken all 

necessary steps to consult with state 

workforce agencies in order to minimize 

the burden of collecting the information 

while adhering to ARRA payment and 

monitoring provisions. 

Darrin A. King, 

Departmental Clearance Officer. 

[FR Doc. E9–4279 Filed 2–27–09; 8:45 am] 

BILLING CODE 4510–FW–P 

DEPARTMENT OF LABOR 

Office of the Secretary 

Submission for OMB Review: 

Comment Request 

February 23, 2009 

The Department of Labor (DOL) 

hereby announces the submission of the 

following public information collection 

request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995 

(Pub. L. 104–13, 44 U.S.C. chapter 35). 

A copy of this ICR, with applicable 

supporting documentation; including 

among other things a description of the 

likely respondents, proposed frequency 

of response, and estimated total burden 

may be obtained from the RegInfo.gov 

Web site at http://www.reginfo.gov/ 

public/do/PRAMain or by contacting 

Mary Beth Smith-Toomey on 202–693– 

4223 (this is not a toll-free number)/ 

e-mail: DOL_PRA_PUBLIC@dol.gov. 

Interested parties are encouraged to 

send comments to the Office of 

Information and Regulatory Affairs, 

Attn: OMB Desk Officer for the 

Department of Labor—ETA, Office of 

Management and Budget, Room 10235, 

Washington, DC 20503, Telephone: 

202–395–7316/Fax: 202–395–6974 

(these are not toll-free numbers), e-mail: 

OIRA_submission@omb.eop.gov within 

30 days from the date of this publication 

in the Federal Register. In order to 

ensure the appropriate consideration, 


erowe on PROD1PC63 with NOTICES